Category Archives: Growth Hormone

Todays column may make you sleepy and that could be a good thing! For this months Healthy Actions column, our expert is Dr. Eileen Wong, University Hospitals East Region Sleep Lab Medical Director.

June 30, 2022 Before a baby is ever born, critical supply chain problems with nutrition and oxygen can result in premature birth or even death and increase the child and mothers lifelong risk of cardiovascular disease. Scientists have found that a midgestation increase in the hormone leptin, which most of us associate with appetite suppression, produces problematic blood vessel dysfunction and restriction of the babys growth inpreeclampsiathat put mother and baby at risk. Its known that about 20 weeks into a pregnancy, women with preeclampsia experience an increase in the production of leptin by the placenta but the consequences have been unknown.

COLLEGE STATION Only mid-way through June and Texas has already seen extreme heat and very little rain this summer, with the trend predicted to continue. The anticipation of drought can bring many thoughts to mind from water shortages to increased wildfire risk, but what do drought conditions mean for our trees? Drought is defined by a relatively long duration with substantially below-normal precipitation, usually occurring over a large area, and Texas is no stranger to drought

The MarketQuest.biz recently published a research report entitled Global Hormone Replacement Therapy (HRT) Market from 2022 to 2028. The research report provides a comprehensive analysis of the market consisting of the market dynamics, constraints, weaknesses, issues, current trends, and competitive analysis.

Clinicians don't cease diagnosing patients once our clinical work is done. Most of us can recall debating whether to point out an atypical mole or another concerning finding to a stranger in public. Like the doctor back in 2018, who saw a lump on the neck of a woman on TV and reached out via a video on Facebook, which found its way to her.

This weeks top articles: FDA authorizes Moderna, Pfizer-BioNTech COVID-19 vaccines for children down to 6 months of age The FDA today announces the EUA of both Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children aged 6 months and older. Over 300 pediatricians submit personal gun violence testimonies to Congressional record Ahead of the US Senate Judiciary Committee hearing on gun violence prevention, the American Academy of Pediatrics announced the submission of a statement including more than 300 pediatricians sharing their personal testimonies on the subject

Scientists demonstrate that they can control the properties of lab-grown plant material, which could enable the production of wood products with little waste. Because of deforestation, the world loses about 10 million hectares of forest an area about the size of Iceland each year.

By Diana Outlaw, Associate Professor, Biological Sciences, Mississippi State University To my fellow parents and community members in rural America, After the schools closed in March, 2020, we sat out the remainder of the 2020-2021 school year, opting to keep our exceptional child safe at home. Its not so much that we were worried about her being more vulnerable to Covid but that her poor adaptive skills and general lack of hygiene awareness made us extremely apprehensive about the germ-ridden cesspool of an elementary school

D-Keine/E+ via Getty Images Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is a great speculative biotech play to look into. That's because it is expected that it will release results from two phase 3 studies under the PATHFNDR program in 2023.

Breadcrumb Trail Links Author of the article: Company advancing AIM Biologicals development program as a potential therapeutic treatment option for neuromyelitisopticaspectrum disorder (NMOSD) Positive results presented at the 13thInternational Congress on Autoimmunity being held in Athens, Greece Preliminary data with mouse 2D2 models of spontaneousautoimmune encephalomyelitis (EAE) indicate that mouse-adapted AIM Biologicals may reduce optic neuritis, loss of inner nuclear layer neurons and EAE symptoms This advertisement has not loaded yet, but your article continues below. TORONTO, ONTARIO, June 13, 2022 (GLOBE NEWSWIRE) Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (Aeterna or the Company), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced its Autoimmunity Modifying (AIM) Biologicals program has achieved pre-clinical proof-of-concept for the potential treatment of neuromyelitis optica spectrum disorder (NMOSD) (also known as Devic disease), a chronic autoimmune disorder of the brain and spinal cord dominated by inflammation of the optic nerve and spinal cord and which can be fatal in approximately 30% of patients within five years of diagnosis